Bristol Myers Squibb has the first positive phase 3 results under its belt for mezigdomide, a second experimental drug in its much-trumpeted celmod development programme for multiple myeloma. Interim ...
BRISTOL, Tenn. (April 10, 2026) — Christopher Bell made the most of his guest appearance in the NASCAR Craftsman Truck Series ...
CRN’s annual Tech Elite 250 recognizes solution providers in the U.S. and Canada that have achieved top-tier status within the partner programs at some of the leading IT vendors. The Tech Elite 250 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results